Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis
Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the
Tag: targeting
Targeted drug delivery systems for atherosclerosis
A review with 402 references Atherosclerosis is a complex cardiovascular disease driven by multiple factors, including aging, inflammation, oxidative stress,
Multifunctional Molecular Hybrids Photoreleasing Nitric Oxide: Advantages, Pitfalls, and Opportunities
The multifaceted role nitric oxide (NO) plays in human physiology and pathophysiology has opened new scenarios in biomedicine by exploiting
Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery
Hyaluronic acid (HA)-based tumor microenvironment-responsive nanocontainers are attractive candidates for anticancer drug delivery due to HA’s excellent biocompatibility, biodegradability, and
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature
In the last few decades, nose-to-brain delivery has been investigated as an alternative route to deliver molecules to the Central
Lysosomal Targeting of β-Cyclodextrin
β-Cyclodextrin (β-CD) and derivatives are approved therapeutics in >30 clinical settings. β-CDs have also shown promise as therapeutics for treatment
An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy
Cyclodextrins (CDs) attracted increasing interest over the past few years, leading to the emergence of promising anti-tumor nanomedicines. Tackling their
SBEβCD-based nanodelivery system targeting the brain
Neuroinflammation occurs early in Alzheimer’s disease (AD). The initial stage of AD is related to glial dysfunction, which contributes to
Twenty years of research on cyclodextrin conjugates with PAMAM dendrimers
Cyclodextrin (CD) conjugates with starburst polyamidoamine (PAMAM) dendrimer (CDEs), as a new type of polymer-based carriers, were first published in
Adjusting the Structure of β-cyclodextrin to Improve Complexation of Anthraquinone-derived Drugs
A nice example for the tailor-made CD derivatives: CD derivatives containing aromatic triazole ring were studied as potential carriers of